Navigation Links
Transplant Societies Protest FDA Policy in American Journal of Transplantation
Date:3/19/2008

MOUNT LAUREL, N.J., March 19 /PRNewswire-USNewswire/ -- In an Open Letter to the Federal Drug Administrations (FDA), which appears in the April issue of the American Journal of Transplantation (AJT), the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) explain how FDA policy is thwarting the field of transplant medicine in the United States. Flavio Vincenti, MD, president of the AST and one of the letter's authors, described the letter as an appeal to the FDA to reconsider its policy.
Vincenti maintains that FDA policy has:

-- discouraged many transplant centers from participating in clinical

trials of new transplant drugs

-- driven American patients away from enrolling in clinical trials

-- caused drug companies to seek patients outside the U.S. for clinical

trials

-- weakened clinical trial results of innovative transplant drugs

In summary, FDA policy mandates the use of immunosuppressive drugs in organ transplantation clinical trials (in the control arms) that are no longer the preferred regimen of drugs of transplant physicians. The letter can be reviewed by going to http://www.a-s-t.org .

About AST

The American Society of Transplantation (AST) was founded in 1982 and is an organization of more than 2,700 transplant professionals dedicated to improving patient care through the promotion of research, education, advocacy and organ donation. AST provides a forum for the exchange of knowledge, scientific information and expertise in the field of transplantation.

If you are interested in speaking with the letter's primary author, Dr. Vincenti, or would like to receive a copy of the letter, please contact Beth Drost at 215.884.6499.

Contact: Beth Drost

215.884.6499


'/>"/>
SOURCE American Society of Transplantation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New technique improves outcome for living donor liver transplants
2. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
3. A new finding in liver transplantation and antifibrinolytics?
4. Transplant Network Appoints Cynthia Siljestrom CEO
5. NIH grant to Emory and pediatric partners aims to improve kidney transplants for children
6. Study of 137 Meniscus Transplant Procedures in Patients with Arthritis is Presented to the Meniscus Transplantation Study Group at the American Academy of Orthopaedic Surgeons Annual Meeting
7. Survival rates exceed national averages for UCSF heart, liver and lung transplant programs
8. Double Lung Transplant Better for Younger COPD Patients
9. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
10. Race, insurance status affect access to transplantation and kidney disease treatment
11. A device that measures optimum state of an organ prior to transplanting has been patented
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology: